search
Sections List
American Journal News

Medicare starts process for negotiating price cuts for drugs used by millions of Americans

The price cuts would target medication used to treat diabetes, heart failure, blood cancers, kidney disease and other ailments.

By Oliver Willis - August 29, 2023
Share
Prescription drugs
Bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J., July 10, 2018. President Joe Biden's administration announced on Tuesday, Aug. 29, 2023, the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs. (AP Photo/Julio Cortez, File)

The Department of Health and Human Services on Tuesday announced the first 10 drugs for which Medicare would begin negotiating lower prices with pharmaceutical companies. The process is moving forward despite unified Republican opposition in Congress to the Inflation Reduction Act of 2022, which gave the federal government new powers to combat rising drug costs.

“There is no reason why Americans should be forced to pay more than any developed nation for life-saving prescriptions just to pad Big Pharma’s pockets,” President Joe Biden said in a statement announcing the action.

According to the department, more than 8.2 million people with Medicare Part D coverage used the drugs in question between June 1, 2022, and May 1, 2023, the dates used to determine which medications would be involved in the first round of negotiations. Enrollees paid $3.4 billion in 2022 in out-of-pocket costs for the drugs in question, which are used to treat diabetes, heart failure, blood cancers, kidney disease and other ailments.

The drugs are Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara and Fiasp/NovoLog.

The federal health department said the Centers for Medicare and Medicaid Services would begin negotiating with drug companies in 2023 and 2024 and that any lowered prices that were agreed upon would take effect for consumers in 2026.

Advocates for older Americans praised the news.

“Allowing Medicare to negotiate prices for these first 10 drugs will finally bring much needed access and relief to American families, particularly older adults,” AARP executive vice president Nancy LeaMond said in a release. “We cannot overstate how monumental this law is for older Americans’ financial stability and overall health.”

Ramsey Alwin, president and CEO of the National Council on Aging, said in a statement, “Today’s announcement is a game changer for the millions of older adults who rely on these medications every day.”

Biden signed the Inflation Reduction Act into law in 2022 after the legislation passed Congress on a party-line vote with only Democratic support (with a tiebreaking vote in the Senate cast by Vice President Kamala Harris).

Republican members of Congress specifically attacked the provision in the law that led to drug price negotiations.

“Don’t expect drug prices to come down,” then-House Minority Leader Kevin McCarthy said in an Aug. 12, 2022, speech. “This bill would cut treatments and hinder new cures by giving bureaucrats the power to decide what drugs seniors can access. It reduces your options and raises your costs.”

Senate Republicans introduced legislation in October 2022 focused on preventing Medicare from negotiating lower prices. “Price controls never work,” Sen. Mike Lee of Utah, one of the bill’s co-sponsors, said in a statement at the time. “Mandating fixed prescription drug prices will ultimately result in the shortening of American lives.”

House Republicans proposed legislation that would repeal the entire Inflation Reduction Act after winning control of the chamber in the 2022 midterm elections. The bill has not yet advanced to a full House vote.

Republicans running for the party’s presidential nomination have also spoken out against the law. Former President Donald Trump complained about regulations in the bill, Florida Gov. Ron DeSantis promised to repeal it if elected, and former Vice President Mike Pence claimed the law undermined manufacturers’ incentives to create new lifesaving drugs.

Major pharmaceutical companies, which saw their profits rise last year as drug prices increased, also oppose the price negotiation provisions. Merck, Bristol Myers Squibb, Johnson & Johnson, and AstraZeneca have sued the federal government to block negotiations.

Public opinion overwhelmingly favors the law. In a poll of 1,002 voters conducted by Hart Research Aug. 12-14, 88% said they favored Medicare having negotiation powers. Just 12% said they opposed it.

Published with permission of The American Independent Foundation.


AJ News
Subscribe to our newsletter.
Read More
Forced to carry a dying baby, this Texas mother of four says she didn’t think it could happen to her

Forced to carry a dying baby, this Texas mother of four says she didn’t think it could happen to her

By Bonnie Fuller - March 28, 2025
Despite pleas from women and doctors, Texas may implement even more abortion restrictions

Despite pleas from women and doctors, Texas may implement even more abortion restrictions

By Bonnie Fuller - March 28, 2025
GOP-led legislatures ramp up abortion restrictions

GOP-led legislatures ramp up abortion restrictions

By Jesse Valentine - March 18, 2025
HHS slashes vaccine research, amplifies misinformation

HHS slashes vaccine research, amplifies misinformation

By Jesse Valentine - March 11, 2025
Cost, access still barriers to medical care for Black Ohio women

Cost, access still barriers to medical care for Black Ohio women

By Susan Tebben, Ohio Capital Journal - October 15, 2024
Texas’ abortion laws are straining the OB/GYN workforce, new study shows

Texas’ abortion laws are straining the OB/GYN workforce, new study shows

By Eleanor Klibanoff, Texas Tribune - October 08, 2024
AJ News
Latest
House Republicans roll out new plan to decimate Medicaid

House Republicans roll out new plan to decimate Medicaid

By Jesse Valentine - April 24, 2025
Trump White House plans to garnish wages of student loan borrowers

Trump White House plans to garnish wages of student loan borrowers

By Jesse Valentine - April 22, 2025
Megadonor embroiled in ethics scandal gave thousands to Winsome Earle-Sears

Megadonor embroiled in ethics scandal gave thousands to Winsome Earle-Sears

By Jesse Valentine - April 21, 2025
“I Was Terrified To Get Pregnant Again After Having to Flee Tennessee for a Life-Saving Abortion”

“I Was Terrified To Get Pregnant Again After Having to Flee Tennessee for a Life-Saving Abortion”

By Bonnie Fuller - April 21, 2025
Goldman Sachs: Trump’s tariffs will lead to job losses

Goldman Sachs: Trump’s tariffs will lead to job losses

By Jesse Valentine - April 17, 2025
Democrats take stand for wrongly deported Maryland man

Democrats take stand for wrongly deported Maryland man

By Jesse Valentine - April 16, 2025
North Carolina law would make it illegal for Democratic AG to sue Trump

North Carolina law would make it illegal for Democratic AG to sue Trump

By Jesse Valentine - April 11, 2025
Older Americans suffer under Republican slash and burn policies

Older Americans suffer under Republican slash and burn policies

By Jesse Valentine - April 09, 2025
Scott Brown got Trump’s tariff plans for New Zealand very wrong

Scott Brown got Trump’s tariff plans for New Zealand very wrong

By Jesse Valentine - April 08, 2025
Trump admin canceled Social Security contracts to punish Maine governor

Trump admin canceled Social Security contracts to punish Maine governor

By Jesse Valentine - April 03, 2025
Senate Republicans vote to eliminate cap on overdraft fees

Senate Republicans vote to eliminate cap on overdraft fees

By Jesse Valentine - April 03, 2025
Forced to carry a dying baby, this Texas mother of four says she didn’t think it could happen to her

Forced to carry a dying baby, this Texas mother of four says she didn’t think it could happen to her

By Bonnie Fuller - March 28, 2025
Despite pleas from women and doctors, Texas may implement even more abortion restrictions

Despite pleas from women and doctors, Texas may implement even more abortion restrictions

By Bonnie Fuller - March 28, 2025
Trump’s antiwar claims don’t hold up in leaked group chat

Trump’s antiwar claims don’t hold up in leaked group chat

By Jesse Valentine - March 28, 2025
Frontline Republican governors cheer on Department of Ed closure

Frontline Republican governors cheer on Department of Ed closure

By Jesse Valentine - March 26, 2025
GOP-led legislatures ramp up abortion restrictions

GOP-led legislatures ramp up abortion restrictions

By Jesse Valentine - March 18, 2025
HHS slashes vaccine research, amplifies misinformation

HHS slashes vaccine research, amplifies misinformation

By Jesse Valentine - March 11, 2025
Senate Republicans scrap consumer protections for payment apps

Senate Republicans scrap consumer protections for payment apps

By Jesse Valentine - March 10, 2025
Rep. Don Bacon admits he voted for Medicaid cuts

Rep. Don Bacon admits he voted for Medicaid cuts

By - February 28, 2025
Trump admin cracks down on affordable weight-loss treatments

Trump admin cracks down on affordable weight-loss treatments

By Jesse Valentine - February 27, 2025
Republican lawmakers are lying about Medicaid fraud

Republican lawmakers are lying about Medicaid fraud

By Jesse Valentine - February 26, 2025
Trump’s education pick: schools may lose funds for teaching Black history

Trump’s education pick: schools may lose funds for teaching Black history

By Jesse Valentine - February 13, 2025